Here’s what you should know:
1. Mr. Hutchison will build the company’s U.S. sales organization and drive prelaunch activities.
2. Motus plans to launch its Pure-Vu colonoscopy preparation system in the U.S. in 2019.
3. Mr. Hutchinson comes to Motus after serving as Bio2 Medical’s vice president of U.S. sales. He also had a tenure at Medtronic GI Solutions.
4. Motus GI CEO Mark Pomeranz said, “Jeff is an experienced and senior sales leader in the GI space who was a key player in the launch and commercial build out of B RRX prior to its acquisition by Covidien as well as its continued growth under Covidien and then Medtronic. He knows how to build and lead a sales organization to drive new market opportunities in the GI space, and that is exactly why he is joining Motus GI now.”
More articles on gastroenterology:
5 tips to cut ASC supply costs
5 most read GI/endoscopy stories August 2 – 8
USA Today, KHN publish follow-up piece on surgery center safety — 5 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
